Polypeptide medicine storage device

By using pressure regulating valves, microporous membrane filters and automatic exhaust devices in the polypeptide drug storage device, the problems of gas regulation and pollution prevention are solved, and the stability and purity of polypeptide drugs are guaranteed.

CN222005995UActive Publication Date: 2024-11-15ZHUHAI PENGKUN BIOMEDICAL TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202420005764.9
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2024-01-02
Publication Date
2024-11-15
Estimated Expiration
2034-01-02

AI Technical Summary

Technical Problem

The existing polypeptide drug storage devices have shortcomings in gas regulation and pollution prevention, making it difficult to achieve accurate gas regulation and avoid pollution.

Method used

A polypeptide drug storage device is designed, including containers, sealing caps, syringe interfaces, pressure regulating valves, catheter systems and filters, using microporous membrane filters, automatic exhaust devices, magnetic connections, antibacterial materials and temperature sensors to ensure that Accurate regulation of the gas environment and prevent pollution.

Benefits of technology

It achieves accurate regulation and pollution prevention of the gas environment of the polypeptide drug, extends the storage time of the drug, and ensures its stability and purity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222005995U_ABST
    Figure CN222005995U_ABST
Patent Text Reader

Abstract

The embodiment of the utility model provides a polypeptide medicine storage device. The polypeptide medicine storage device comprises a container used for containing polypeptide medicine; a sealing cap for closing the container; the injector interface is positioned on the sealing cover and can be connected with an injector so as to inject or extract polypeptide medicine into or from the container; the pressure regulating valve is positioned on the sealing cover and can control the flowing of the polypeptide medicine in the container by regulating the internal pressure; the guide pipe system is connected below the sealing cover and extends to the bottom of the container, the guide pipe system comprises a feeding guide pipe and a discharging guide pipe, the feeding guide pipe is connected with the pressure regulating valve, and the discharging guide pipe is provided with an exhaust hole; a filter is arranged between the feeding guide pipe and the discharging guide pipe in the guide pipe system, and the filter is a microporous membrane. Through the scheme of the embodiment of the invention, the problems of how to realize accurate gas regulation and avoid pollution can be solved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biotechnology, and in particular relates to a polypeptide drug storage device. Background Art

[0002] A peptide drug storage device is a device used to store and protect peptide drugs. It usually consists of a sealed container containing peptide drugs and necessary auxiliary materials. This device can effectively extend the shelf life of peptide drugs and ensure that they still have good activity and stability before use.

[0003] However, this type of peptide drug storage device has problems such as how to achieve accurate gas regulation and avoid contamination. First, for some sensitive peptide drugs, the gas environment may have a significant impact on their stability. Therefore, during the storage process, the gas composition and pressure inside the container need to be precisely controlled to ensure optimal storage conditions.

[0004] In addition, avoiding contamination is also a key issue. Since peptide drugs are often very fragile and susceptible to contamination sources such as tiny particles or bacteria in the external environment, corresponding measures need to be taken to prevent contamination when designing the device. For example, during the manufacturing process, attention should be paid to the use of aseptic techniques and the selection of appropriate materials to construct sealed containers to prevent the intrusion of external microorganisms. Summary of the invention

[0005] In view of this, an embodiment of the present disclosure provides a polypeptide drug storage device, which at least partially solves the problems existing in the prior art.

[0006] A polypeptide drug storage device disclosed herein comprises:

[0007] A container for containing a polypeptide drug;

[0008] a sealing cap for closing the container;

[0009] A syringe interface located on the sealing cover, which can be connected to a syringe to inject or extract the polypeptide drug into the container;

[0010] A pressure regulating valve located on the sealing cover, which can control the flow of the polypeptide drug in the container by adjusting the internal pressure;

[0011] A conduit system connected to the bottom of the sealing cover and extending to the bottom of the container, including a feed conduit and a discharge conduit, wherein the feed conduit is preferably connected to a pressure regulating valve, and the discharge conduit has a vent hole; and

[0012] A filter is arranged between the feed conduit and the discharge conduit in the conduit system, and the filter is a microporous membrane.

[0013] Preferably, a pressure sensor is provided on the sealing cover to monitor the internal pressure of the container and to achieve accurate gas regulation by controlling the pressure regulating valve.

[0014] Preferably, the syringe interface on the sealing cover is detachably designed to facilitate replacement of syringes of different specifications, and a sealed structure is also provided between the sealing cover and the syringe interface.

[0015] Preferably, an automatic exhaust device is provided on the discharge conduit in the conduit system, which can automatically exhaust air and other impurities when injecting or extracting the polypeptide drug.

[0016] Preferably, the feed conduit and the discharge conduit in the conduit system are connected magnetically, and a sealing ring is provided between the feed conduit and the discharge conduit.

[0017] Preferably, the syringe interface on the sealing cap is equipped with a temperature sensor for monitoring the internal temperature of the container.

[0018] Preferably, a rotatable or tiltable bracket is provided at the bottom of the container, so that the polypeptide drug flows more evenly in the container, thereby achieving accurate gas regulation.

[0019] Preferably, the feed conduit and the discharge conduit in the conduit system are of telescopic design, so that the length of the conduit can be adjusted as needed and the problem of inaccurate gas regulation caused by being too long or too short can be avoided.

[0020] Preferably, a layer of antibacterial material is coated on the surface of the feed conduit and the discharge conduit in the conduit system to prevent bacteria from growing and contaminating the polypeptide drug.

[0021] Preferably, a sealing device is provided between the feed conduit and the discharge conduit in the conduit system.

[0022] The disclosed embodiment provides a polypeptide drug storage device, including: a container for accommodating polypeptide drugs; a sealing cover for closing the container; a syringe interface located on the sealing cover, which can be connected to a syringe to inject or extract polypeptide drugs into the container; a pressure regulating valve located on the sealing cover, which can control the flow of polypeptide drugs in the container by adjusting the internal pressure; a conduit system connected to the bottom of the sealing cover and extending to the bottom of the container, including a feed conduit and a discharge conduit, wherein the feed conduit is connected to the pressure regulating valve, and the discharge conduit has an exhaust hole; and a filter is provided between the feed conduit and the discharge conduit in the conduit system, and the filter is a microporous membrane. Through the solution of the disclosed embodiment, the problem of how to achieve accurate gas regulation and avoid contamination can be solved. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] In order to more clearly illustrate the technical solutions of the exemplary implementation methods of the embodiments of the present disclosure, the drawings required for use in the embodiments will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the embodiments of the present disclosure and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.

[0024] Figure 1 This is an overall structural diagram of a polypeptide drug storage device provided by the utility model;

[0025] Figure 2 A cross-sectional view of a polypeptide drug storage device provided by the utility model;

[0026] Figure 3 This is a structural diagram of a catheter system of a polypeptide drug storage device provided by the utility model.

[0027] Figure markings: 1-container; 2-sealing cover; 3-syringe interface; 4-pressure regulating valve; 5-catheter system; 6-feeding conduit; 7-discharging conduit; 8-exhaust hole; 9-filter; 10-microporous membrane; 11-pressure sensor; 12-automatic exhaust device; 13-sealing ring; 14-antibacterial material; 15-sealing device; 16-temperature sensor; 17-bracket; 18-magnetic connection. DETAILED DESCRIPTION

[0028] In order to make the purpose, technical solutions and advantages of the embodiments of the present disclosure more clear, the embodiments of the present disclosure are further described in detail in combination with the embodiments and drawings. The schematic implementation methods of the embodiments of the present disclosure and their descriptions are only used to explain the embodiments of the present disclosure and are not intended to limit the embodiments of the present disclosure.

[0029] refer to Figure 1 and Figure 2 The polypeptide drug storage device of the utility model is a device for storing and managing polypeptide drugs. The device comprises a container 1 for containing polypeptide drugs, a sealing cover 2, a syringe interface 3, a pressure regulating valve 4 and a catheter system 5 (see Figure 2 ).

[0030] First, the polypeptide drug storage device includes a container 1 for containing the polypeptide drug. The container 1 can be a vial or other shapes suitable for storing liquids. It must have sufficient sealing performance to ensure that the polypeptide drug inside is not contaminated by the external environment.

[0031] Secondly, the device also includes a sealing cover 2 for closing the container 1. The sealing cover 2 must be able to completely cover the container 1 and have good sealing performance to prevent air or other pollutants from entering the container 1.

[0032] A syringe interface 3 is also provided on the sealing cover 2. The syringe interface 3 can be connected to a syringe so as to inject or extract the polypeptide drug into the container 1. Through this interface, a doctor or a patient can conveniently use a syringe to manage and use the polypeptide drug.

[0033] In addition, a pressure regulating valve 4 is provided on the sealing cover 2. The pressure regulating valve 4 can control the flow of the polypeptide drug in the container 1 by adjusting the internal pressure. This is very important because the polypeptide drug may change due to factors such as temperature and pressure, and its stability needs to be maintained by adjusting the pressure.

[0034] See also Figure 2 , connected to the sealing cover 2 is a conduit system 5, which extends to the bottom of the container 1 and can lead out the polypeptide drug. The conduit system 5 includes a feed conduit 6 and a discharge conduit 7. The feed conduit 6 is connected to the pressure regulating valve 4 to ensure that the polypeptide drug can be smoothly injected from the container 1 into the conduit system 5 and flow under appropriate pressure. The discharge conduit 7 has a vent 8 (see Figure 3 ) is used to release the gas or excess liquid generated inside the container 1.

[0035] In a specific embodiment, the container 1 is made of a material suitable for storing polypeptide drugs and ensures that it has sufficient strength and tolerance. The sealing cover 2 is designed to be a lid that can completely seal the container 1 to prevent the polypeptide drug from leaking or being contaminated by the outside world. The syringe interface 3 is arranged on the sealing cover 2 and is compatible with the syringe, so that the user can inject or extract the polypeptide drug into the container 1 by connecting the syringe. This interface may adopt a standardized design, such as a Luer-Lock connection. The pressure regulating valve 4 is installed on the sealing cover 2 and is connected to the feed conduit 6. The flow rate of the polypeptide drug in the container 1 is controlled by adjusting the internal pressure. This pressure regulating valve 4 can be adjustable so that the drug flow rate can be adjusted as needed.

[0036] Specifically, the pressure regulating valve 4 can apply pressure to the container 1 in a manner similar to an air pump, and in the process draw the polypeptide drug into the feed conduit 6 and thus into the conduit system 5 .

[0037] The conduit system 5 includes a feed conduit 6 and a discharge conduit 7. The feed conduit 6 is connected to the pressure regulating valve 4 to introduce the polypeptide drug into the container 1. The discharge conduit 7 has an exhaust hole 8 to ensure that air can be discharged smoothly when the polypeptide drug is injected or extracted.

[0038] In one embodiment, a cylindrical container 1 made of a polymer material can be used as a container 1 for storing polypeptide drugs. The sealing cover 2 can be made of rubber or silicone and is equipped with a Luer-Lock interface and an adjustable pressure regulating valve 4. The feed conduit 6 is connected to the sealing cover 2 by connecting to the pressure regulating valve 4, and the entire device is constructed through a discharge conduit 7 extending to the bottom of the container 1. In this way, when using the device, the user can inject or extract the polypeptide drug into the container 1 through the syringe interface 3, and control the flow rate of the drug in the conduit system 5 by controlling the pressure regulating valve 4. At the same time, during operation, the exhaust hole 8 can ensure that the air can be discharged smoothly from the discharge conduit 7.

[0039] In a specific embodiment, a polypeptide drug storage device disclosed in the present invention includes a sealing cover 2 and a pressure sensor 11. The pressure sensor 11 is used to monitor the pressure inside the container 1 and to achieve accurate gas regulation by controlling the pressure regulating valve 4.

[0040] In one embodiment, a micro pressure sensor 11 can be installed on the sealing cover 2 of the polypeptide drug storage device. The sensor can monitor the gas pressure inside the container 1 in real time and transmit the data to the control system. The control system adjusts the gas flow and pressure level by controlling the pressure regulating valve 4 connected to the container 1 according to the preset parameters. When the gas pressure inside the container 1 exceeds or falls below the set range, the control system will automatically open or close the regulating valve to maintain a stable gas environment.

[0041] In this way, by using the pressure sensor 11 disposed on the sealing cover 2 and the control system and regulating valve matched therewith, the gas environment inside the polypeptide drug storage device can be accurately and reliably regulated and maintained.

[0042] In a specific embodiment, a polypeptide drug storage device disclosed herein has a syringe interface 3 that is detachable, so as to facilitate replacement of syringes of different specifications and effectively avoid drug contamination.

[0043] In one embodiment, the device may include a sealing cover 2 and a syringe interface 3 fixed on the sealing cover 2. The syringe interface 3 may have a detachable structure, and in one embodiment, a threaded connection or a quick plug-in mechanism. When a syringe of a different specification needs to be replaced, the user can easily remove the original syringe from the interface and install a new syringe. This detachable design makes the device suitable for syringes of various specifications and types.

[0044] In addition, during the installation process, a closed environment protection measure may be provided between the sealing cover 2 and the syringe interface 3. In one embodiment, an O-ring or other closed structure may be provided at the connection to ensure that no air or foreign matter enters the storage area during the replacement process. In this way, the drug can be effectively prevented from being contaminated when replacing syringes of different specifications.

[0045] In a specific embodiment, Figure 3 As shown, a filter 9 is provided in the conduit system 5 of a polypeptide drug storage device disclosed in the present invention to filter possible contaminants. The filter 9 is located between the feed conduit 6 and the discharge conduit 7 to prevent contaminants from entering the discharge conduit 7.

[0046] In one embodiment, a microporous membrane 10 can be used as the filter 9 in the device. The microporous membrane 10 has a very small pore size and can effectively block contaminants such as bacteria, viruses and other microorganisms at the nanometer level. When the drugs flow into the device through the feed conduit 6, they must pass through this microporous membrane 10 filter 9 for screening. Only pure drugs that meet the set standards can pass through the microporous membrane 10 and finally flow to the discharge conduit 7.

[0047] In addition, other types of filters 9 can also be used to achieve this feature. In one embodiment, an adsorption filter 9 made of materials such as activated carbon adsorbent or ion exchange resin can be used to adsorb and remove possible pollutants on its surface. These adsorption filters 9 can be installed between the feed conduit 6 and the discharge conduit 7, and remove pollutants through chemical reaction or physical adsorption.

[0048] In a specific embodiment, an automatic exhaust device 12 is provided on the discharge conduit 7 in the conduit system 5 of a polypeptide drug storage device disclosed in the present invention. The automatic exhaust device 12 has the following functions: when injecting or extracting polypeptide drugs, it can automatically exhaust air and other impurities.

[0049] In one embodiment, this feature can be achieved by the following technical means: a controllable valve or piston mechanism is set on the discharge conduit 7 and connected to a sensor. When the polypeptide drug is injected or extracted, the sensor detects the fluid entering or leaving the conduit system 5 and sends a signal to the valve or piston mechanism. According to the signal, the valve or piston mechanism will open to allow the fluid to pass through, and at the same time close to prevent air and impurities from entering. Once the fluid stops entering or leaving, the sensor will send a signal to the valve or piston mechanism again to close it to keep the system sealed.

[0050] In addition, other technical means can be used to achieve this feature during the implementation process. In one embodiment, a microporous filter is provided on the discharge conduit 7, which can filter out air and impurities and only allow the polypeptide drug to pass through. In addition, a vacuum pump can also be used to extract the polypeptide drug, and air and impurities are automatically removed during the operation of the pump.

[0051] In a specific embodiment, the feeding conduit 6 and the discharging conduit 7 in the conduit system 5 of the polypeptide drug storage device disclosed in the present invention are characterized by a magnetic connection 18. This magnetic connection 18 is intended to improve the connection stability and avoid leakage.

[0052] Specifically, a connection component with magnetic material can be used to construct the feed conduit 6 and the discharge conduit 7. In one embodiment, a connector with a magnet or other magnetic elements can be installed at the ends of the feed conduit 6 and the discharge conduit 7. When the two conduits need to be connected, their ends will be attracted together and remain firmly connected together by magnetic force.

[0053] In addition, a sealing device 15 such as a sealing ring 13 or an O-ring can be provided between the feed conduit 6 and the discharge conduit 7 to ensure that the connection does not leak. These sealing devices 15 can prevent drugs or other liquids from leaking out of the connection and maintain the integrity of the entire system.

[0054] By adopting this magnetic connection 18, the polypeptide drug storage device can realize a more reliable, stable and leak-free catheter system 5. At the same time, since there is no need to use traditional mechanical connection methods such as threads or buckles, the device has the advantages of being simpler, more convenient and faster to assemble and disassemble.

[0055] In a specific embodiment, in a polypeptide drug storage device disclosed herein, the syringe interface 3 on the sealing cover 2 is equipped with a temperature sensor 16. The sensor is used to monitor the temperature inside the container 1 and perform corresponding temperature adjustment as needed.

[0056] In one embodiment, a micro temperature sensor 16 can be used and installed at the syringe interface 3 on the sealing cover 2. The sensor can be connected to the control system through electronic components to monitor the temperature changes inside the container 1 in real time. When it is detected that the temperature exceeds or falls below the set threshold, the control system will automatically start the corresponding adjustment mechanism.

[0057] In order to achieve the temperature regulation function, a variety of technical means can be used. In one embodiment, a heat-sensitive material or a cooling device is added to the device to provide heat or reduce the temperature as needed. In addition, electromagnetic heating, heat storage materials, fans and other technologies can also be used to achieve precise temperature control.

[0058] In a specific embodiment, a polypeptide drug storage device disclosed herein includes a rotatable or tiltable support 17 disposed at the bottom of a container 1. The function of the support 17 is to make the flow of the polypeptide drug in the container 1 more uniform, thereby achieving accurate gas regulation.

[0059] In one embodiment, this feature can be achieved by installing a rotating shaft and a corresponding driving device at the bottom of the container 1. When the driving device is started, the rotating shaft drives the bracket 17 to rotate. In this way, the polypeptide drug will flow with the movement of the bracket 17, and due to the fluid mechanics effect, the drug distribution is more uniform.

[0060] Another implementation method is to set a tiltable bracket 17. In this case, the bracket 17 can adjust the tilt angle as needed. When the tilt angle changes, the polypeptide drug will also move and redistribute accordingly.

[0061] Regardless of which method is used to achieve this feature, the flow of the polypeptide drug in the container 1 can be effectively promoted during use, and the gas regulation process can be ensured to be accurate.

[0062] In a specific embodiment, the conduit system 5 of a polypeptide drug storage device disclosed in the present invention, wherein the feed conduit 6 and the discharge conduit 7 are retractable. This design allows the conduit length to be adjusted as needed to avoid inaccurate gas regulation caused by being too long or too short.

[0063] In one embodiment, this feature can be achieved by using retractable materials in the feed conduit 6 and the discharge conduit 7. These retractable materials can be elastic polymers or metal alloys, etc. When the conduit length needs to be adjusted, the user can stretch or shrink these materials to adapt them to the required length and lock them in the selected position through a fixing mechanism.

[0064] Another way to achieve this is to use a catheter with a foldable structure. These foldable structures can include multiple connected parts that unfold when needed to form a continuous catheter path. Users can unfold or fold these structures as needed to adjust the catheter length and keep it in the desired position through a locking mechanism.

[0065] In a specific embodiment, in a polypeptide drug storage device disclosed herein, the surfaces of the feed conduit 6 and the discharge conduit 7 of the conduit system 5 are coated with a layer of antibacterial material 14. Such a design is intended to prevent bacteria from growing and contaminating the polypeptide drug.

[0066] In order to achieve this feature, materials with antibacterial properties can be used to coat the surfaces of the feed conduit 6 and the discharge conduit 7. These antibacterial materials 14 can be polymer coatings containing antimicrobial agents or other chemical components. In one embodiment, compounds containing silver ions, iodine ions or chloride ions that have the ability to inhibit bacterial growth can be used to prepare the coating. These compounds can be combined with the conduit surface by copolymerization, sol-gel method or electrodeposition.

[0067] In addition, nanotechnology can also be used to achieve this feature. In one embodiment, nanoparticles are added to the coating, which are highly stable and durable and have a killing effect on bacteria. These nanoparticles can be metal oxides (such as titanium dioxide) or other nanomaterials with microbial inhibitory activity.

[0068] In a specific embodiment, in a polypeptide drug storage device disclosed herein, a sealing device 15 is provided between a feed conduit 6 and a discharge conduit 7 in a conduit system 5 to prevent external air from entering the container 1 and affecting the quality of the polypeptide drug.

[0069] In one embodiment, in the technical solution for realizing this feature, a sealing ring 13 or a sealing gasket can be used as a sealing device 15. This sealing device 15 can be installed between the feed conduit 6 and the discharge conduit 7, and ensure that the connection between the two conduits is completely airtight. When the polypeptide drug needs to be injected or extracted, the sealing device 15 can only be opened through a specially designed interface, thereby preventing outside air from entering the container 1. This can effectively protect the polypeptide drug from contamination and ensure that its quality is not affected by any adverse factors.

[0070] The working process of the polypeptide drug storage device of this embodiment is as follows:

[0071] First, the polypeptide drug is placed in the container 1, and the container is closed with the sealing cover 2. Then, the syringe is connected to the syringe interface 3 located on the sealing cover 2. The polypeptide drug can be injected into or extracted from the container 1 through the syringe.

[0072] The pressure regulating valve 4 on the sealing cover 2 plays a role in controlling the flow of the polypeptide drug. By adjusting the internal pressure, the flow speed and amount of the polypeptide drug can be controlled.

[0073] The conduit system 5 is connected to the bottom of the sealing cover 2 and extends to the bottom of the container 1. The feed conduit 6 is connected to the pressure regulating valve 4 to ensure that the correct pressure is delivered to the polypeptide drug. The discharge conduit 7 has a vent 8 to release gas when needed.

[0074] The specific implementation methods described above further illustrate the purpose, technical solutions and beneficial effects of the embodiments of the present disclosure. It should be understood that the above description is only the specific implementation method of the embodiments of the present disclosure and is not intended to limit the protection scope of the embodiments of the present disclosure. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the embodiments of the present disclosure should be included in the protection scope of the embodiments of the present disclosure.

Claims

1. A polypeptide drug storage device, characterized in that: include: A container (1) for containing a polypeptide drug; A sealing cover (2) for closing the container (1); A syringe interface (3) located on the sealing cover (2) is used to inject or extract the polypeptide drug into the container (1); A pressure regulating valve (4) located on the sealing cover (2), which can control the flow of the polypeptide drug in the container (1) by adjusting the internal pressure; a conduit system (5) connected to the bottom of the sealing cover (2) and extending to the bottom of the container, comprising a feed conduit (6) and a discharge conduit (7), wherein the feed conduit (6) is connected to the pressure regulating valve (4), and the discharge conduit (7) has a vent hole (8); and A filter (9) is arranged between the feed conduit (6) and the discharge conduit (7) in the conduit system, and the filter (9) is a microporous membrane (10).

2. A polypeptide drug storage device according to claim 1, characterized in that: A pressure sensor (11) is arranged on the sealing cover (2) to monitor the internal pressure of the container (1) and to perform gas regulation by controlling the pressure regulating valve (4).

3. A polypeptide drug storage device according to claim 1, characterized in that: The syringe interface (3) on the sealing cover (2) is of detachable design so as to facilitate replacement of syringes of different specifications, and a sealing structure is also provided between the sealing cover (2) and the syringe interface (3).

4. A polypeptide drug storage device according to claim 1, characterized in that: An automatic exhaust device (12) is provided on the discharge conduit (7) in the conduit system, and is used to exhaust air when injecting or extracting the polypeptide drug.

5. A polypeptide drug storage device according to claim 1, characterized in that: The feed conduit (6) and the discharge conduit (7) in the conduit system (5) are connected magnetically (18), and a sealing ring (13) is provided between the feed conduit (6) and the discharge conduit (7).

6. A polypeptide drug storage device according to claim 1, characterized in that: The syringe interface (3) on the sealing cover (2) is equipped with a temperature sensor (16) for monitoring the internal temperature of the container (1).

7. A polypeptide drug storage device according to claim 1, characterized in that: A support (17) is provided at the bottom of the container (1).

8. A polypeptide drug storage device according to claim 1, characterized in that: The feed conduit (6) and the discharge conduit (7) in the conduit system (5) are of telescopic design.

9. A polypeptide drug storage device according to claim 1, characterized in that: The surfaces of the feed conduit (6) and the discharge conduit (7) in the conduit system (5) are coated with a layer of antibacterial material (14).

10. A polypeptide drug storage device according to claim 1, characterized in that: A sealing device (15) is provided between the feed conduit (6) and the discharge conduit (7) in the conduit system (5).